Good news | Synergistic effect of triple active ingredients of "natural silk fibroin+recombinant collagen+sodium hyaluronate" - "medical silk fibroin compound gel" has been approved for marketing!
On March 18, the "medical silk fibroin compound gel" independently developed by the subsidiary of Xingyue Biology - Sirui Biotechnology (Zhejiang) Co., Ltd. (hereinafter referred to as "Sirui Biology") was officially granted the National Medical Device Registration Certificate (ZXZZ 20252141196).
As the latest achievement of the "Silk An Yan" brand, this product integrates three bioactive ingredients: natural silk fibroin protein, recombinant collagen protein, and sodium hyaluronate. Among them, silk fibroin is derived from high-quality mulberry silk, which is finely extracted and purified to retain its natural biocompatibility. Recombinant collagen is produced using internationally leading DNA recombination technology, and sodium hyaluronate is produced by microbial fermentation. The product breaks through the limitations of traditional raw materials, achieving high-purity water locking and moisturizing, creating a moist healing environment. The synergistic effect of the triple active ingredients can significantly activate the wound repair mechanism, providing innovative solutions for the coverage and care of non chronic wounds after laser surgery.
In terms of preparation process, the entire product line adopts environmentally friendly technologies such as biological enzymatic hydrolysis and low-temperature freeze-drying, which not only effectively reduces energy consumption, but also ensures high quality and purity of the product from the source. This product is building a new paradigm of beauty medicine with three core components as its engine. At the same time, the "Silky Beauty" series products, with "regenerated silk fibroin protein" as the core ingredient, help the industry iterate and upgrade towards more precision, efficiency, and safety, bringing new hope and choices to every beauty seeker.
At present, Xingyue Biotechnology has successfully established a full industry chain technology barrier from raw material extraction to achievement transformation. Relying on the research and development platform of Zhejiang Province Key Laboratory of Tissue Engineering and Regenerative Medicine Technology, it will continue to deepen the strategic layout of medical silk materials and accelerate the transformation and application of technological achievements.
